1. Home
  2. ATLN vs NKTR Comparison

ATLN vs NKTR Comparison

Compare ATLN & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLN
  • NKTR
  • Stock Information
  • Founded
  • ATLN 2014
  • NKTR 1990
  • Country
  • ATLN United States
  • NKTR United States
  • Employees
  • ATLN N/A
  • NKTR N/A
  • Industry
  • ATLN
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATLN
  • NKTR Health Care
  • Exchange
  • ATLN NYSE
  • NKTR Nasdaq
  • Market Cap
  • ATLN 137.6M
  • NKTR 160.4M
  • IPO Year
  • ATLN 2021
  • NKTR 1994
  • Fundamental
  • Price
  • ATLN $4.20
  • NKTR $0.68
  • Analyst Decision
  • ATLN
  • NKTR Strong Buy
  • Analyst Count
  • ATLN 0
  • NKTR 5
  • Target Price
  • ATLN N/A
  • NKTR $5.50
  • AVG Volume (30 Days)
  • ATLN 76.9K
  • NKTR 1.5M
  • Earning Date
  • ATLN 01-01-0001
  • NKTR 03-12-2025
  • Dividend Yield
  • ATLN N/A
  • NKTR N/A
  • EPS Growth
  • ATLN N/A
  • NKTR N/A
  • EPS
  • ATLN N/A
  • NKTR N/A
  • Revenue
  • ATLN $442,609,814.00
  • NKTR $98,427,000.00
  • Revenue This Year
  • ATLN N/A
  • NKTR N/A
  • Revenue Next Year
  • ATLN N/A
  • NKTR N/A
  • P/E Ratio
  • ATLN N/A
  • NKTR N/A
  • Revenue Growth
  • ATLN 10.27
  • NKTR 9.21
  • 52 Week Low
  • ATLN $1.30
  • NKTR $0.65
  • 52 Week High
  • ATLN $8.98
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • ATLN N/A
  • NKTR 31.49
  • Support Level
  • ATLN N/A
  • NKTR $0.84
  • Resistance Level
  • ATLN N/A
  • NKTR $0.92
  • Average True Range (ATR)
  • ATLN 0.00
  • NKTR 0.07
  • MACD
  • ATLN 0.00
  • NKTR -0.02
  • Stochastic Oscillator
  • ATLN 0.00
  • NKTR 3.95

About ATLN ATLANTIC INTERNATIONAL CORP

Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: